SEC Form 4 · accession 0001144204-15-032895
NANOVIRICIDES, INC. · NNVC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Milton Boniuk
Director
Period of report
May 19, 2015
Accepted (ET)
May 21, 2015 · 3:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001379006
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001F1 | May 19, 2015 | P | 25,000 | $1.60 | A | 1,480,391 | D | |
| Common Stock, par value $0.001F1 | May 20, 2015 | P | 25,000 | $1.60 | A | 1,505,391 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 933,963 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife. Does not include: 942,859 shares of Common Stock, warrants to purchase an additional 285,714 shares of Common Stock or an indeterminate number of shares of Common Stock issuable upon conversion of debentures held by Boniuk Interests, Ltd.; 571,431 shares of Common Stock held by the Boniuk Charitable Foundation; or 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible. Dr. Boniuk holds voting and dispositive power over the Boniuk Charitable Foundation, Boniuk Interests Ltd. and the Milton Boniuk IRA.